NCT00001685 2008-03-04Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and TyrosinaseNational Institutes of Health Clinical Center (CC)Phase 2 Completed114 enrolled